Tech Digest

Israel, Where the Baby Boom Lives On

Stay Up to Date!

Simply enter your email below and click SIGN UP!

From Bioscience Expert Patrick Cox - The Most Life-Changing Book You'll Read This Year - Click Here

November 6, 2017

Dear Reader,

There are many factors that contribute to the West's general economic malaise. The biggest and most intractable though is aging demographics. The cost of care for the elderly (especially health care) takes up an increasingly larger percentage of resources as the population ages.

Social Security, Medicare, and Medicaid have grown to make up about half of the US federal budget. This is the only part of the federal budget, other than debt service, that is growing in proportion to the total.

At the same time, the number of people paying into the system is falling due to sub-replacement birthrates. There appears to be no viable political solution to this quandary.

It is difficult if not impossible to solve this problem by increasing taxes or cutting spending. Higher taxes take resources from the private sector, which slows economic growth in the long run. On the other hand, spending cuts prompt political outrage. As a result, the US and many other countries are engaging in deficit spending to fund rising age-related costs. But that resultant debt must be serviced, which reduces current and future spending. The result, once again, is political outrage.

While I'm doubtful that a political solution exists, I'm confident that there is an answer. It comes from biotech.

The cost of aging can be significantly reduced by emerging medical technologies. The balance between the old and the young can be restored by treating aging itself. Since most people are forced to retire for health reasons, people will choose to be productive longer as healthspans are extended.

The stakes are enormous. The West is headed for a financial cliff caused by aging. There is one notable exception, however. 

Here’s Why Israel Is Known As the Startup Nation

Israel has its share of problems, but population aging isn't one of them. This is a remarkably young and vibrant country. It is also a country focused on health and health care. I've read that Israel has more doctors per capita than any other nation. If it's not true, I'd be surprised.

I’m in Tel Aviv, Israel, at the moment. The reason is that I was invited to visit the world-renowned Weizmann Institute of Science. I was willing to travel halfway around the world to get additional sources of information about Israeli biotechnology.

For the most part, biotechnology is a North American game. Europe and Asia have some great scientists, but the leading research centers are concentrated on the coasts of the US. Nature has ranked the most important scientific groups based on their overall impact on the process of science. The Weizmann Institute is the only organization outside the New World that consistently ranks among the top. 

In my lifetime, Israel has shifted from an agricultural to a tech economy. Orange groves have been replaced by research groups for many of the world's most important companies. It is symbolically appropriate that the Weizmann Institute is named for the country's first president, Dr. Chaim Weizmann, a biologist himself. It says something about the values of a country that its first president was a scientist.

Though its population is less than 9 million, Israel is a powerhouse of science and technology today. Called the “startup nation,” Israel lags behind only the US and China in numbers of newly established companies. Similarly, it ranks number three in hosting the largest NASDAQ-listed companies.

So I’m not here for tourism. If there's a gene allele for enjoying exotic faraway locations, I don't have it. Travel interferes with my workouts, and I hate airports. Nevertheless, I will travel to meet the right people, and there are people here I want to know.

Israel has important scientists, but the country's demographics are also important. Its fertility rate of more than 3 children per woman makes it the single most notable exception to the rule of the demographic transition.

That rule is simple. Birthrates fall as populations live longer and grow wealthier. The US, Canada, Europe, and Scandinavia all have birthrates below 2.1 children per woman, which is below replacement rate. So the developed world is depopulating. Japan and Singapore are now shrinking by half per generation.

Israel, on the other hand, is growing by half per generation. This holds across Israeli society, regardless of ethnicity, religious conviction, or lack thereof. You can see it in the baby carriages on the sidewalks of Jerusalem and the teeming nightclubs of Tel Aviv.

As a result, the percentage of young workers to older retirees is high in Israel. The burden of the aged is borne by a growing number of younger workers, so capital is available for other uses, including research, innovation, and startups.

In fact, Israel’s economy has outperformed most of the world for the last five years. GDP growth last year was 4% despite serious over-regulation. Israel has the talent, energy, and desire to play a key role in the war on aging.

Already, I've met people working on the bleeding edge of quantum computing, computational biology, and synthetic biology. In this column, I'm not going to go into any detail on any of these fields. But I promise that I'll have much more to report from Israel in the future.

One breakthrough that I do want to tell you about involves a company that appears to have the ability to cure most forms of blindness. But I'll save that for another time.

Patrick Cox
Patrick Cox
Editor, Transformational Technology Alert

Mauldin Economics


Stay in the Loop on Life-Extending Research
with Patrick Cox's Tech Digest

Tech Digest

Your privacy is very important to us. Please review our Privacy Policy.


« Back to Articles

From Bioscience Expert Patrick Cox - The Most Life-Changing Book You'll Read This Year - Click Here

Discuss This


We welcome your comments. Please comply with our Community Rules.


Nov. 6, 2017, 2:22 p.m.

It seems even if you delay the affects of aging you will still have to deal with them later. While seniors could be more productive there needs to be an economic infrastructure that provides employment for them and a market that is capable of supporting the goods output that will be generated by increased employment.

James Pitre

Nov. 6, 2017, 11:40 a.m.

Good article and well thought out. I am adding to the old age tilt in our demographics. Fortunatley still in good health, however my time will come to add to the healthcare problem. In the US much of the current cost issue is associated with our healthcare has simply opened the doors to excesses for the benefit of the few who are reaping giant rewards at the top.

It seems to me that much of the underlying cause(s) for our overall health challenge has to do with our food chain and lifestyle - both of which we have consciously chosen without care or regard for the unintended consequesnces. Industrial farming including animal husbandry has focussed on how to produce at the lowest cost that will produce the highest profit without regard to the primary objective of providing healthy nutrition and strong bodies that will ward off many of the aging diseases that are causing the health crisis.

Our bodies appear to be quite capable of remaining relatively strong an productive into our 80s, so to me our job is to find ways to feed our population, provide preventative health care and promote healthy lifestyles starting with children is our long term solution. Clear out the majority of the highly processed foods from our stores and educate people about the importance of good food. None of the processed foods designed for addiction and profit measure up to the age old standards practiced by many for centuries such as Kosher, Halal, organic and other practices of good nutrition & health, and consequently our food chain is in great measure resonsible for our health crisis.

Rod Watson

Nov. 6, 2017, 11:24 a.m.

Cochrane’s book The 10,000 Year Explosion: How Civilization Accelerated Human EvolutionOct 19, 2010 has a piece that also partly explains Israel’s success—he says the Western European Jewish community has an average IQ of 115 or 1 standard deviation higher than normal.
As I remember, he stated that they have received 30% of the Nobel prizes from .03% of the population

Use of this content, the Mauldin Economics website, and related sites and applications is provided under the Mauldin Economics Terms & Conditions of Use.

Unauthorized Disclosure Prohibited

The information provided in this publication is private, privileged, and confidential information, licensed for your sole individual use as a subscriber. Mauldin Economics reserves all rights to the content of this publication and related materials. Forwarding, copying, disseminating, or distributing this report in whole or in part, including substantial quotation of any portion the publication or any release of specific investment recommendations, is strictly prohibited.
Participation in such activity is grounds for immediate termination of all subscriptions of registered subscribers deemed to be involved at Mauldin Economics’ sole discretion, may violate the copyright laws of the United States, and may subject the violator to legal prosecution. Mauldin Economics reserves the right to monitor the use of this publication without disclosure by any electronic means it deems necessary and may change those means without notice at any time. If you have received this publication and are not the intended subscriber, please contact


The Mauldin Economics website, Thoughts from the Frontline, The Weekly Profit, The 10th Man, Connecting the Dots, Transformational Technology Digest, Over My Shoulder, Yield Shark, Transformational Technology Alert, Rational Bear, Street Freak, ETF 20/20, In the Money, and Mauldin Economics VIP are published by Mauldin Economics, LLC Information contained in such publications is obtained from sources believed to be reliable, but its accuracy cannot be guaranteed. The information contained in such publications is not intended to constitute individual investment advice and is not designed to meet your personal financial situation. The opinions expressed in such publications are those of the publisher and are subject to change without notice. The information in such publications may become outdated and there is no obligation to update any such information. You are advised to discuss with your financial advisers your investment options and whether any investment is suitable for your specific needs prior to making any investments.
John Mauldin, Mauldin Economics, LLC and other entities in which he has an interest, employees, officers, family, and associates may from time to time have positions in the securities or commodities covered in these publications or web site. Corporate policies are in effect that attempt to avoid potential conflicts of interest and resolve conflicts of interest that do arise in a timely fashion.
Mauldin Economics, LLC reserves the right to cancel any subscription at any time, and if it does so it will promptly refund to the subscriber the amount of the subscription payment previously received relating to the remaining subscription period. Cancellation of a subscription may result from any unauthorized use or reproduction or rebroadcast of any Mauldin Economics publication or website, any infringement or misappropriation of Mauldin Economics, LLC’s proprietary rights, or any other reason determined in the sole discretion of Mauldin Economics, LLC.

Affiliate Notice

Mauldin Economics has affiliate agreements in place that may include fee sharing. If you have a website or newsletter and would like to be considered for inclusion in the Mauldin Economics affiliate program, please go to Likewise, from time to time Mauldin Economics may engage in affiliate programs offered by other companies, though corporate policy firmly dictates that such agreements will have no influence on any product or service recommendations, nor alter the pricing that would otherwise be available in absence of such an agreement. As always, it is important that you do your own due diligence before transacting any business with any firm, for any product or service.

© Copyright 2018 Mauldin Economics